PT2641912T - Processo para a obtenção de uma composição de igg através de tratamento térmico - Google Patents

Processo para a obtenção de uma composição de igg através de tratamento térmico

Info

Publication number
PT2641912T
PT2641912T PT131585523T PT13158552T PT2641912T PT 2641912 T PT2641912 T PT 2641912T PT 131585523 T PT131585523 T PT 131585523T PT 13158552 T PT13158552 T PT 13158552T PT 2641912 T PT2641912 T PT 2641912T
Authority
PT
Portugal
Prior art keywords
obtaining
heat treatment
igg composition
igg
composition
Prior art date
Application number
PT131585523T
Other languages
English (en)
Portuguese (pt)
Inventor
Ristol Debart Pere
Grancha Gamon Salvador
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46053016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2641912(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of PT2641912T publication Critical patent/PT2641912T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A61K39/39525—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT131585523T 2012-03-20 2013-03-11 Processo para a obtenção de uma composição de igg através de tratamento térmico PT2641912T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201230413A ES2381828B1 (es) 2012-03-20 2012-03-20 PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO

Publications (1)

Publication Number Publication Date
PT2641912T true PT2641912T (pt) 2016-08-12

Family

ID=46053016

Family Applications (1)

Application Number Title Priority Date Filing Date
PT131585523T PT2641912T (pt) 2012-03-20 2013-03-11 Processo para a obtenção de uma composição de igg através de tratamento térmico

Country Status (21)

Country Link
US (1) US9200032B2 (enExample)
EP (1) EP2641912B1 (enExample)
JP (2) JP6048936B2 (enExample)
KR (1) KR101840064B1 (enExample)
CN (1) CN103319592B (enExample)
AR (1) AR090337A1 (enExample)
AU (1) AU2013201853B2 (enExample)
BR (1) BR102013006411A2 (enExample)
CA (1) CA2809513C (enExample)
CL (1) CL2013000688A1 (enExample)
ES (2) ES2381828B1 (enExample)
HU (1) HUE027915T2 (enExample)
IL (1) IL225197A (enExample)
MX (1) MX339268B (enExample)
MY (1) MY165024A (enExample)
PL (1) PL2641912T3 (enExample)
PT (1) PT2641912T (enExample)
RU (1) RU2636049C2 (enExample)
SG (1) SG193738A1 (enExample)
TW (1) TWI554283B (enExample)
UY (1) UY34679A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2990033A1 (fr) * 2014-08-26 2016-03-02 Carlina Technologies Procédé de préparation de nanoprécipites de peptide ou protéine de faible poids moléculaire
PL3135687T3 (pl) * 2015-08-31 2019-09-30 Instituto Grifols, S.A. Sposób wytwarzania immunoglobulin
RU2708394C2 (ru) * 2016-09-26 2019-12-06 Институто Грифольс,С.А. Способ получения иммуноглобулинов
MA52204A (fr) * 2018-04-12 2021-02-17 Amgen Inc Procédés de préparation de compositions protéiques stables
CN112557643B (zh) * 2019-09-26 2023-04-14 菲鹏生物股份有限公司 变性IgG和类风湿因子免疫抗原及制备方法
CN112858671B (zh) * 2019-11-27 2022-12-27 菲鹏生物股份有限公司 制备类风湿因子检测试剂的方法、类风湿因子检测试剂、试剂盒和检测方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US514375A (en) 1894-02-06 miller
CA1064396A (en) 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4165370A (en) 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
DE3176491D1 (en) 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4396608A (en) 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
ES8206184A1 (es) 1981-10-29 1982-08-16 Green Cross Corp Un procedimiento para preparar una immunoglobulina adecuada para inyeccion intravenosa
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
JPH0825902B2 (ja) 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
JPH0662436B2 (ja) 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
CA1310267C (en) 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
ES2091161B1 (es) * 1995-04-12 1997-05-16 Grifols Grupo Sa Procedimiento para la produccion de gammaglobulina intramuscular inactivada por pasteurizacion.
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)
ES2421736T3 (es) * 1998-06-09 2013-09-05 Csl Behring Ag Procedimiento para la preparación de inmunoglobulinas para administración intravenosa y otros productos inmunoglobulínicos
TR200100303T2 (tr) * 1998-06-09 2001-06-21 Statens Serum Institut Damardan uygulanacak immünoglobülinler üretmek için yöntem ve başka immünoglobülin ürünleri.
CN1137727C (zh) * 1998-06-25 2004-02-11 四川远大蜀阳药业有限公司 无保护剂双重病毒灭活制备静注免疫球蛋白工艺
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
ATE468755T1 (de) * 2004-05-07 2010-06-15 Wisconsin Alumni Res Found Verfahren und zusammensetzungen mit molkeproteinisolaten
KR101226353B1 (ko) * 2007-06-01 2013-01-24 에프. 호프만-라 로슈 아게 면역글로불린 정제
US8796430B2 (en) * 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield

Also Published As

Publication number Publication date
AU2013201853A1 (en) 2013-10-10
TW201343179A (zh) 2013-11-01
IL225197A0 (en) 2013-06-27
EP2641912B1 (en) 2016-06-15
SG193738A1 (en) 2013-10-30
MX339268B (es) 2016-05-18
MX2013002910A (es) 2013-09-19
KR101840064B1 (ko) 2018-03-19
UY34679A (es) 2013-10-31
ES2381828A1 (es) 2012-06-01
US20140113355A1 (en) 2014-04-24
TWI554283B (zh) 2016-10-21
AR090337A1 (es) 2014-11-05
JP6048936B2 (ja) 2016-12-21
IL225197A (en) 2017-06-29
HK1185625A1 (en) 2014-02-21
JP2016199586A (ja) 2016-12-01
CN103319592A (zh) 2013-09-25
CL2013000688A1 (es) 2014-02-28
CA2809513A1 (en) 2013-09-20
MY165024A (en) 2018-02-28
ES2381828B1 (es) 2012-11-16
US9200032B2 (en) 2015-12-01
BR102013006411A2 (pt) 2015-06-09
PL2641912T3 (pl) 2016-11-30
HUE027915T2 (en) 2016-11-28
KR20130106792A (ko) 2013-09-30
AU2013201853B2 (en) 2014-07-03
JP2013194054A (ja) 2013-09-30
RU2013112276A (ru) 2014-09-27
RU2636049C2 (ru) 2017-11-17
EP2641912A1 (en) 2013-09-25
ES2590045T3 (es) 2016-11-17
CN103319592B (zh) 2020-03-03
CA2809513C (en) 2016-09-27

Similar Documents

Publication Publication Date Title
IL235826A (en) Diazaspirocycloalkanes and thenaspirocycloalkanes and their preparation
GB2500903B (en) Heating apparatus
SG11201502095SA (en) Methods for treating hepatitis c
ZA201302579B (en) Apparatus for performing heat treatment
GB201222999D0 (en) Cooling process
SG11201502108RA (en) Methods for treating hepatitis c
GB2522807B (en) Infra-red device for focused heating
IL225197A0 (en) A process for obtaining a preparation of IgG by heat treatment
EP2816126A4 (en) THERMAL TREATMENT METHOD
GB201413757D0 (en) Apparatus for heating water
PL2809760T3 (pl) Sposób zmniejszania przykrych zapachów
PL2815195T3 (pl) Urządzenie do obróbki cieplnej
HUP1300660A2 (en) Apparatus for cooling, heating of (human) body
GB2488391B (en) Heating apparatus
PT2817305T (pt) Um processo melhorado para a preparação de aprepitant
ZA201302015B (en) PROCESS FOR OBTAINING AN IgG COMPOSITION THROUGH HEAT TREATMENT
SG11201602010VA (en) Heat treatment method
PL2527772T3 (pl) Urządzenie grzejne
AP2015008271A0 (en) Method for producing an agent for the treatment oftuberculosis
EP2718633A4 (en) INSTANT HEATING APPARATUS
GB201217804D0 (en) Apparatus for heating
GB201601543D0 (en) Heating apparatus
GB201221068D0 (en) Heating apparatus
GB201221051D0 (en) Heating apparatus
GB201105753D0 (en) Heating/cooling apparatus